{
    "root": "49f038e3-fb63-4e87-a7b8-8aa07cf208e2",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Quetiapine",
    "value": "20250301",
    "ingredients": [
        {
            "name": "QUETIAPINE FUMARATE",
            "code": "2S3PL1B6UJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_8708"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "DIBASIC CALCIUM PHOSPHATE DIHYDRATE",
            "code": "O7TSZ97GEP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_77635"
        },
        {
            "name": "HYPROMELLOSE 2910 (15 MPA.S)",
            "code": "36SFW2JZ0W",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POVIDONE K25",
            "code": "K0KQV10C35",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11061"
        },
        {
            "name": "POVIDONE K27",
            "code": "H7AGY1OJO8",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11061"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9661"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "HYPROMELLOSE 2910 (3 MPA.S)",
            "code": "0VUT3PMY82",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "HYPROMELLOSE 2910 (50 MPA.S)",
            "code": "1IVH67816N",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "POLYDEXTROSE",
            "code": "VH2XOU12IE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_181906"
        },
        {
            "name": "POLYETHYLENE GLYCOL 8000",
            "code": "Q662QK8M3B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        }
    ],
    "indications": {
        "text": "quetiapine atypical antipsychotic indicated treatment : schizophrenia ( 1.1 ) bipolar disorder manic episodes ( 1.2 ) bipolar disorder , depressive episodes ( 1.2 )",
        "doid_entities": [
            {
                "text": "schizophrenia (DOID:5419)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5419"
            },
            {
                "text": "bipolar disorder (DOID:3312)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3312"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "quetiapine tablets taken without food ( 2.1 ) indication initial dose recommended dose maximum dose schizophrenia-adults ( 2.2 ) 25 mg twice daily 150 750 mg/day 750 mg/day schizophrenia-adolescents ( 13 17 years ) ( 2.2 ) 25 mg twice daily 400 800 mg/day 800 mg/day bipolar mania- adults monotherapy adjunct lithium divalproex ( 2.2 ) 50 mg twice daily 400 800 mg/day 800 mg/day bipolar mania-children adolescents ( 10 17 years ) , monotherapy ( 2.2 ) 25 mg twice daily 400 600 mg/day 600 mg/day bipolar depression-adults ( 2.2 ) 50 mg daily bedtime 300 mg/day 300 mg/day geriatric : consider lower starting dose ( 50 mg/day ) , slower titration careful monitoring initial dosing period elderly ( 2.3 , 8.5 ) hepatic impairment : lower starting dose ( 25 mg/day ) slower titration may needed ( 2.4 , 8.7 , 12.3 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "quetiapine tablets , usp available follows : 25 mg \u2013 light orange , round , biconvex , film-coated , unscored tablets , debossed \u201c 93 \u201d one side \u201c v7 \u201d side , bottles 100 ( ndc 0093-2063-01 ) . 50 mg \u2013 white off-white , round , biconvex , film-coated , unscored tablets , debossed \u201c 93 \u201d one side \u201c 8166 \u201d side , bottles 100 ( ndc 0093-8166-01 ) . 100 mg \u2013 light orange , round , biconvex , film-coated , unscored tablets , debossed \u201c 93 \u201d one side \u201c 8162 \u201d side , bottles 100 ( ndc 0093-8162-01 ) . 200 mg \u2013 white off-white , round , biconvex , film-coated , unscored tablets , debossed \u201c 93 \u201d one side \u201c 8163 \u201d side , bottles 100 ( ndc 0093-8163-01 ) . 300 mg \u2013 pale yellow , capsule-shaped , biconvex , film-coated , unscored tablets , debossed \u201c 93 \u201d one side \u201c 8164 \u201d side , bottles 100 ( ndc 0093-8164-01 ) . 400 mg \u2013 white off-white , capsule-shaped , biconvex , film-coated , unscored tablets , debossed \u201c 93 \u201d one side \u201c 8165 \u201d side , bottles 100 ( ndc 0093-8165-01 ) . store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . dispense tight , light-resistant container defined usp , child-resistant closure ( required ) . keep medications reach children .",
    "adverseReactions": "hypersensitivity quetiapine excipients quetiapine tablets formulation . anaphylactic reported patients treated quetiapine .",
    "indications_original": "Quetiapine is an atypical antipsychotic indicated for the treatment of: Schizophrenia ( 1.1 ) Bipolar I disorder manic episodes ( 1.2 ) Bipolar disorder, depressive episodes ( 1.2 )",
    "contraindications_original": "Quetiapine tablets can be taken with or without food ( 2.1 ) Indication Initial Dose Recommended Dose Maximum Dose Schizophrenia-Adults ( 2.2 ) 25 mg twice daily 150 to 750 mg/day 750 mg/day Schizophrenia-Adolescents (13 to 17 years) ( 2.2 ) 25 mg twice daily 400 to 800 mg/day 800 mg/day Bipolar Mania- Adults Monotherapy or as an adjunct to lithium or divalproex ( 2.2 ) 50 mg twice daily 400 to 800 mg/day 800 mg/day Bipolar Mania-Children and Adolescents (10 to 17 years), Monotherapy ( 2.2 ) 25 mg twice daily 400 to 600 mg/day 600 mg/day Bipolar Depression-Adults ( 2.2 ) 50 mg once daily at bedtime 300 mg/day 300 mg/day Geriatric Use: Consider a lower starting dose (50 mg/day), slower titration and careful monitoring during the initial dosing period in the elderly ( 2.3 , 8.5 ) Hepatic Impairment: Lower starting dose (25 mg/day) and slower titration may be needed ( 2.4 , 8.7 , 12.3 )",
    "warningsAndPrecautions_original": "Quetiapine tablets, USP are available as follows:\n                  25 mg \u2013 light orange, round, biconvex, film-coated, unscored tablets, debossed with \u201c93\u201d on one side and \u201cV7\u201d on the other side, in bottles of 100 (NDC 0093-2063-01).\n                  50 mg \u2013 white to off-white, round, biconvex, film-coated, unscored tablets, debossed with \u201c93\u201d on one side and \u201c8166\u201d on the other side, in bottles of 100 (NDC 0093-8166-01).\n                  100 mg \u2013 light orange, round, biconvex, film-coated, unscored tablets, debossed with \u201c93\u201d on one side and \u201c8162\u201d on the other side, in bottles of 100 (NDC 0093-8162-01).\n                  200 mg \u2013 white to off-white, round, biconvex, film-coated, unscored tablets, debossed with \u201c93\u201d on one side and \u201c8163\u201d on the other side, in bottles of 100 (NDC 0093-8163-01).\n                  300 mg \u2013 pale yellow, capsule-shaped, biconvex, film-coated, unscored tablets, debossed with \u201c93\u201d on one side and \u201c8164\u201d on the other side, in bottles of 100 (NDC 0093-8164-01).\n                  400 mg \u2013 white to off-white, capsule-shaped, biconvex, film-coated, unscored tablets, debossed with \u201c93\u201d on one side and \u201c8165\u201d on the other side, in bottles of 100 (NDC 0093-8165-01).\n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature].\n                  Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).\n                  Keep this and all medications out of the reach of children.",
    "adverseReactions_original": "Hypersensitivity to quetiapine or to any excipients in the quetiapine tablets formulation. Anaphylactic reactions have been reported in patients treated with quetiapine.",
    "drug": [
        {
            "name": "Quetiapine",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_8707"
        }
    ]
}